CLASS II Drug recall · Reported 19 Dec 2018 · FDA Enforcement Report
Thyroid Powder, USP/drum recalled by LGM Pharma
LGM Pharma is recalling Thyroid Powder, USP/drum, distributed nationwide in the US. The recall was initiated on 24 Aug 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0296-2019
- FDA event ID
- 81606
- Recalling firm
- LGM Pharma, Erlanger, KY
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 24 Aug 2018
- FDA classified
- 12 Dec 2018
- Reported
- 19 Dec 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Thyroid Medication
Timeline
| 24 Aug 2018 | Recall initiated by company | |
| 12 Dec 2018 | Classified by FDA | +110 days |
| 19 Dec 2018 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Product as listed by the FDA
Thyroid Powder, USP, 25kg/drum, Rx Only, Sichuan Friendly Pharmaceutical Co., LTD. NDC: 070870-1701-1
Where it was distributed
Nationwide in the USA
Questions about this recall
Why was it recalled?
CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Which lots are affected?
Lots: 161101, EXP 11/2/2016; 161201, EXP Nov 2018; 170301, EXP Feb 2019; 170501, Exp Apr 2019; 170701, Exp Jun 2019
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from LGM Pharma
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cidofovir Dihydrate, (Non-Sterile, For Manufacturing Use) recalled | LGM Pharma | Manufacturing (CGMP) Deviations | MS |
Other Thyroid recalls
All 11| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Thyroid recalled by Specialty Process Labs | Specialty Process Labs | Potency & Assay | Nationwide |
| Drug | CLASS II | Armour Thyroid (thyroid tablets, USP), 2 Grain (120 mg) recalledArmour Thyroid | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain recalled | Humco Holding Group | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Thyroid, USP (Full Strength) Levothyroxine 112.1 mcg/grain recalled | Humco Holding Group | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain recalled | Humco Holding Group | Manufacturing (CGMP) Deviations | Nationwide |